{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:35:11Z","timestamp":1778668511848,"version":"3.51.4"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ejps.2019.105094","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T12:17:25Z","timestamp":1571141845000},"page":"105094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Convection enhanced delivery of anti-angiogenic and cytotoxic agents in combination therapy against brain tumour"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0268-5042","authenticated-orcid":false,"given":"Wenbo","family":"Zhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2019.105094_bib0001","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s11095-009-9945-8","article-title":"Role of convective flow in carmustine delivery to a brain tumor","volume":"26","author":"Arifin","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2019.105094_bib0002","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11060-018-2747-2","article-title":"Localized targeted antiangiogenic drug delivery for glioblastoma","volume":"137","author":"Arnone","year":"2018","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.ejps.2019.105094_bib0003","series-title":"The Cancer Imaging Archive","article-title":"Data from RIDER_NEURO_MRI","author":"Barboriak","year":"2015"},{"key":"10.1016\/j.ejps.2019.105094_bib0004","doi-asserted-by":"crossref","first-page":"19059","DOI":"10.1073\/pnas.1318022110","article-title":"Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation","volume":"110","author":"Batchelor","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2019.105094_bib0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ccr.2006.11.021","article-title":"a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients","volume":"11","author":"Batchelor","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejps.2019.105094_bib0006","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0026-2862(89)90074-5","article-title":"Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection","volume":"37","author":"Baxter","year":"1989","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.ejps.2019.105094_bib0007","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0026-2862(90)90023-K","article-title":"Transport of fluid and macromolecules in tumors. II. Role of heterogeneous perfusion and lymphatics","volume":"40","author":"Baxter","year":"1990","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.ejps.2019.105094_bib0008","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0026-2862(91)90003-T","article-title":"Transport of fluid and macromolecules in tumors: III. Role of binding and metabolism","volume":"41","author":"Baxter","year":"1991","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.ejps.2019.105094_bib0009","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1124\/mol.65.6.1496","article-title":"DNA damage-processing pathways involved in the eukaryotic cellular response to anticancer DNA cross-linking drugs","volume":"65","author":"Beljanski","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejps.2019.105094_bib0010","doi-asserted-by":"crossref","unstructured":"V. Benitez, M.A. Karajannis, Chemotherapy of brainstem gliomas, in: Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy, Elsevier, 2018, 585\u2013596.","DOI":"10.1016\/B978-0-12-812100-9.00046-2"},{"key":"10.1016\/j.ejps.2019.105094_bib0011","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mvr.2019.03.003","article-title":"Comparison of transport of chemotherapeutic drugs in voxelized heterogeneous model of human brain tumor","volume":"124","author":"Bhandari","year":"2019","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.ejps.2019.105094_bib0012","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jbiomech.2017.05.017","article-title":"Perfusion kinetics in human brain tumor with DCE-MRI derived model and CFD analysis","volume":"59","author":"Bhandari","year":"2017","journal-title":"J Biomech"},{"key":"10.1016\/j.ejps.2019.105094_bib0013","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1038\/sj.onc.1207374","article-title":"The spindle checkpoint, aneuploidy, and cancer","volume":"23","author":"Bharadwaj","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.ejps.2019.105094_bib0014","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/neuonc\/noq142","article-title":"Targeted therapy for high-grade glioma with the TGF-\u03b22 inhibitor trabedersen: results of a randomized and controlled phase IIb study","volume":"13","author":"Bogdahn","year":"2010","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.ejps.2019.105094_bib0015","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1083\/jcb.200805072","article-title":"Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied","volume":"182","author":"Brito","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejps.2019.105094_bib0016","first-page":"3084","article-title":"Bulk transfer of fluid in the interstitial compartment of mammary tumors","volume":"35","author":"Butler","year":"1975","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2019.105094_bib0017","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0378-5173(85)90010-9","article-title":"Prodrugs of 5-fluorouracil. III. Hydrolysis kinetics in aqueous solution and biological media, lipophilicity and solubility of various 1-carbamoyl derivatives of 5-fluorouracil","volume":"23","author":"Buur","year":"1985","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.105094_bib0018","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1039\/c2jm15277k","article-title":"Reducible self-assembled micelles for enhanced intracellular delivery of doxorubicin","volume":"22","author":"Chen","year":"2012","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.ejps.2019.105094_bib0019","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0021-9258(17)42175-2","article-title":"Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair","volume":"269","author":"Chu","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2019.105094_bib0020","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s10278-013-9622-7","article-title":"The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository","volume":"26","author":"Clark","year":"2013","journal-title":"J. Digit. Imag."},{"key":"10.1016\/j.ejps.2019.105094_bib0021","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0009-2797(80)90128-3","article-title":"Preparation and metabolism of a cisplatin\/serum protein complex","volume":"30","author":"Cole","year":"1980","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejps.2019.105094_bib0022","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1021\/mp700086j","article-title":"Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability","volume":"5","author":"Dhanikula","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2019.105094_bib0023","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/jnci\/djj070","article-title":"Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers","volume":"98","author":"Dreher","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejps.2019.105094_bib0024","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-4682-6-16","article-title":"A tumor cord model for doxorubicin delivery and dose optimization in solid tumors","volume":"6","author":"Eikenberry","year":"2009","journal-title":"Theor. Biol. Med. Modell.."},{"key":"10.1016\/j.ejps.2019.105094_bib0025","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/nm.3289","article-title":"Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy","volume":"19","author":"Emblem","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejps.2019.105094_bib0026","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/1097-0142(20011001)92:7<1936::AID-CNCR1712>3.0.CO;2-H","article-title":"Long\u2010term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin","volume":"92","author":"Fabel","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ejps.2019.105094_bib0027","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.colsurfb.2006.05.005","article-title":"Doxorubicin biocompatible O\/W microemulsion stabilized by mixed surfactant containing soya phosphatidylcholine","volume":"51","author":"Formariz","year":"2006","journal-title":"Colloid. Surf.B"},{"key":"10.1016\/j.ejps.2019.105094_bib0028","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1200\/JCO.2008.19.8721","article-title":"Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma","volume":"27","author":"Friedman","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejps.2019.105094_bib0029","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.addr.2018.07.006","article-title":"Top-down fabrication of shape-controlled, monodisperse nanoparticles for biomedical applications","volume":"132","author":"Fu","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2019.105094_bib0030","first-page":"672","article-title":"Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain","volume":"58","author":"Fung","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2019.105094_bib0031","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1023\/A:1016083113123","article-title":"Chemotherapeutic drugs released from polymers: distribution of 1, 3-bis (2-chloroethyl)-l-nitrosourea in the rat brain","volume":"13","author":"Fung","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2019.105094_bib0032","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0378-5173(97)00430-4","article-title":"Effect of oleic acid\/ethanol and oleic acid\/propylene glycol on the in vitro percutaneous absorption of 5-fluorouracil and tamoxifen and the macroscopic barrier property of porcine epidermis","volume":"165","author":"Gao","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.105094_bib0033","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.biomaterials.2016.07.037","article-title":"PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma","volume":"105","author":"Gaudin","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2019.105094_bib0034","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1158\/0008-5472.671.65.3","article-title":"Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies","volume":"65","author":"Gerber","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2019.105094_bib0035","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1023\/A:1011076110317","article-title":"Simulation of the delivery of doxorubicin to hepatoma","volume":"18","author":"Goh","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2019.105094_bib0036","series-title":"Handbook\/edici\u00f3n","article-title":"Perry's chemical engineers","author":"Green","year":"1973"},{"key":"10.1016\/j.ejps.2019.105094_bib0037","first-page":"3417","article-title":"Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols","volume":"43","author":"Greene","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2019.105094_bib0038","unstructured":"J.F. Gross, A.S. Popel, Mathematical Models of Transport Phenomena in Normal and Neoplastic Tissue, CRC Press, Boca Raton, FL, USA, 1979."},{"key":"10.1016\/j.ejps.2019.105094_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1005894723087","article-title":"Chemotherapy in experimental brain tumor, part 1: in vitro colorimetric MTT assay","volume":"36","author":"Hand","year":"1998","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.ejps.2019.105094_bib0040","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/1097-0142(19860201)57:3<461::AID-CNCR2820570310>3.0.CO;2-6","article-title":"Differential macromolecular leakage from the vasculature of tumors","volume":"57","author":"Heuser","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.ejps.2019.105094_bib0041","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1007\/s11095-009-9947-6","article-title":"Permeation enhancer-containing water-in-oil nanoemulsions as carriers for intravesical cisplatin delivery","volume":"26","author":"Hwang","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2019.105094_bib0042","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0143-7208(01)00035-3","article-title":"Diffusion coefficients for direct dyes in aqueous and polar aprotic solvents by the NMR pulsed-field gradient technique","volume":"50","author":"Inglesby","year":"2001","journal-title":"Dye. Pigment."},{"key":"10.1016\/j.ejps.2019.105094_bib0043","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3171\/2016.1.JNS151591","article-title":"Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies","volume":"126","author":"Jahangiri","year":"2017","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ejps.2019.105094_bib0044","first-page":"3039","article-title":"Transport of molecules in the tumor interstitium: a review","volume":"47","author":"Jain","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2019.105094_bib0045","doi-asserted-by":"crossref","first-page":"R1810","DOI":"10.1152\/ajpregu.1997.273.5.R1810","article-title":"A finite element model for predicting the distribution of drugs delivered intracranially to the brain, American Journal of Physiology-Regulatory","volume":"273","author":"Kalyanasundaram","year":"1997","journal-title":"Integrat. Comparat. Physiol."},{"key":"10.1016\/j.ejps.2019.105094_bib0046","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/0006-2952(86)90195-4","article-title":"Comparative intracellular uptake of adriamycin and 4\u2032-deoxydoxorubicin by nonsmall cell lung tumor cells in culture and its relationship to cell survival","volume":"35","author":"Kerr","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2019.105094_bib0047","first-page":"2013","article-title":"Cisplatin therapy in recurrent childhood brain tumors","volume":"66","author":"Khan","year":"1982","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.ejps.2019.105094_bib0048","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.neuroscience.2004.07.033","article-title":"Water homeostasis in the brain: basic concepts","volume":"129","author":"Kimelberg","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejps.2019.105094_bib0049","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/790721","article-title":"Quantitative model for efficient temporal targeting of tumor cells and neovasculature","volume":"2011","author":"Kohandel","year":"2011","journal-title":"Comput. Math. Methods Med."},{"key":"10.1016\/j.ejps.2019.105094_bib0050","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1088\/0031-9155\/52\/13\/001","article-title":"Dynamics of tumor growth and combination of anti-angiogenic and cytotoxic therapies","volume":"52","author":"Kohandel","year":"2007","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.ejps.2019.105094_bib0051","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2009.24.8252","article-title":"Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance","volume":"28","author":"Kopetz","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejps.2019.105094_bib0052","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1200\/JCO.2008.16.3055","article-title":"Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma","volume":"27","author":"Kreisl","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejps.2019.105094_bib0053","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0022-3565(24)39296-1","article-title":"Computational model of intracellular pharmacokinetics of paclitaxel","volume":"293","author":"Kuh","year":"2000","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejps.2019.105094_bib0054","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3171\/jns.1984.60.6.1134","article-title":"BCNU solubility and toxicity in the treatment of malignant astrocytomas","volume":"60","author":"Layton","year":"1984","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ejps.2019.105094_bib0055","first-page":"265","article-title":"Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions","volume":"51","author":"Less","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2019.105094_bib0056","first-page":"2071","article-title":"BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumors","volume":"62","author":"Levin","year":"1978","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.ejps.2019.105094_bib0057","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3171\/jns.2004.100.3.0472","article-title":"Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I\/II clinical study","volume":"100","author":"Lidar","year":"2004","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ejps.2019.105094_bib0058","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1021\/js9605226","article-title":"Solid\u2010state characterization of paclitaxel","volume":"86","author":"Liggins","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.105094_bib0059","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jtbi.2007.09.009","article-title":"Prediction of convection-enhanced drug delivery to the human brain","volume":"250","author":"Linninger","year":"2008","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.ejps.2019.105094_bib0060","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1109\/TBME.2008.923920","article-title":"Rigorous mathematical modeling techniques for optimal delivery of macromolecules to the brain","volume":"55","author":"Linninger","year":"2008","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"10.1016\/j.ejps.2019.105094_bib0061","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.compbiomed.2015.03.008","article-title":"A systematic study of temperature sensitive liposomal delivery of doxorubicin using a mathematical model","volume":"60","author":"Liu","year":"2015","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ejps.2019.105094_bib0062","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1595\/147106708X324845","article-title":"Novel lipophilic platinum (II) compounds of salicylate derivatives","volume":"52","author":"Liu","year":"2008","journal-title":"Platin Met. Rev."},{"key":"10.1016\/j.ejps.2019.105094_bib0063","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejps.2019.105094_bib0064","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3171\/2014.10.JNS14229","article-title":"Convection-enhanced delivery to the central nervous system","volume":"122","author":"Lonser","year":"2015","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ejps.2019.105094_bib0065","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00280-007-0664-8","article-title":"Clinical pharmacokinetics of bevacizumab in patients with solid tumors","volume":"62","author":"Lu","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejps.2019.105094_bib0066","first-page":"335","article-title":"In vitro and in vivo protein binding of methotrexate assessed by microdialysis","volume":"34","author":"Maia","year":"1996","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2019.105094_bib0067","first-page":"4971","article-title":"Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging","volume":"61","author":"Mardor","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2019.105094_bib0068","doi-asserted-by":"crossref","first-page":"871","DOI":"10.7863\/jum.2009.28.7.871","article-title":"Experimental study on targeted methotrexate delivery to the rabbit brain via magnetic resonance imaging\u2013guided focused ultrasound","volume":"28","author":"Mei","year":"2009","journal-title":"J. Ultrasound Med."},{"key":"10.1016\/j.ejps.2019.105094_bib0069","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jconrel.2005.11.018","article-title":"Fabrication and characterization of microfluidic probes for convection enhanced drug delivery","volume":"111","author":"Neeves","year":"2006","journal-title":"J. Controll. Release"},{"key":"10.1016\/j.ejps.2019.105094_bib0070","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1517\/14656561003796562","article-title":"Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel","volume":"11","author":"Petrelli","year":"2010","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejps.2019.105094_bib0071","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/foc.2006.20.4.7","article-title":"Convection-enhanced delivery of therapeutics for brain disease, and its optimization","volume":"20","author":"Raghavan","year":"2006","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.ejps.2019.105094_bib0072","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s10439-010-9957-x","article-title":"Poroviscoelastic modeling of liver biomechanical response in unconfined compression","volume":"38","author":"Raghunathan","year":"2010","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.ejps.2019.105094_bib0073","doi-asserted-by":"crossref","first-page":"13481","DOI":"10.1073\/pnas.172501499","article-title":"Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics","volume":"99","author":"Rajagopalan","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2019.105094_bib0074","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.2007.14.9930","article-title":"Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study","volume":"26","author":"Saltz","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejps.2019.105094_bib0075","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/0009-2509(91)80036-X","article-title":"Drugs released from polymers: diffusion and elimination in brain tissue","volume":"46","author":"Saltzman","year":"1991","journal-title":"Chem. Eng. Sci."},{"key":"10.1016\/j.ejps.2019.105094_bib0076","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: overcoming blood\u2013brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Controll. Release"},{"key":"10.1016\/j.ejps.2019.105094_bib0077","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1124\/jpet.108.149443","article-title":"Use of an anti-vascular endothelial growth factor antibody in a pharmacokinetic strategy to increase the efficacy of intraperitoneal chemotherapy","volume":"329","author":"Shah","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejps.2019.105094_bib0078","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.clinthera.2006.11.015","article-title":"Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies","volume":"28","author":"Shih","year":"2006","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejps.2019.105094_bib0079","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874364101004010028","article-title":"Sustained intraocular pressure elevation after intravitreal injection of bevacizumab and ranibizumab associated with trabeculitis","volume":"4","author":"Sniegowski","year":"2010","journal-title":"Open Ophthalmol. J."},{"key":"10.1016\/j.ejps.2019.105094_bib0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1754-1611-6-4","article-title":"Effect of tumor shape and size on drug delivery to solid tumors","volume":"6","author":"Soltani","year":"2012","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.ejps.2019.105094_bib0081","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharmacy Pharmacol."},{"key":"10.1016\/j.ejps.2019.105094_bib0082","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2011.05.020","article-title":"Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system","volume":"154","author":"Tagami","year":"2011","journal-title":"Journal of controlled release"},{"key":"10.1016\/j.ejps.2019.105094_bib0083","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2006.24.18_suppl.4597","article-title":"Antitumor effects of sorafenib and sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC) who had prior therapy with anti-angiogenic agents","volume":"24","author":"Tamaskar","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejps.2019.105094_bib0084","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3171\/jns.1977.46.2.0165","article-title":"Intraneoplastic injection of methotrexate for experimental brain-tumor chemotherapy","volume":"46","author":"Tator","year":"1977","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ejps.2019.105094_bib0085","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10822-005-8694-y","article-title":"Virtual computational chemistry laboratory\u2013design and description","volume":"19","author":"Tetko","year":"2005","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejps.2019.105094_bib0086","doi-asserted-by":"crossref","first-page":"14325","DOI":"10.1073\/pnas.1518808112","article-title":"Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients","volume":"112","author":"Tolaney","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2019.105094_bib0087","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1200\/JCO.2008.17.5984","article-title":"Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034","volume":"27","author":"van den Bent","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejps.2019.105094_bib0088","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ana.10688","article-title":"Imaging\u2010guided convection\u2010enhanced delivery and gene therapy of glioblastoma","volume":"54","author":"Voges","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejps.2019.105094_bib0089","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s13311-016-0510-y","article-title":"New directions in anti-angiogenic therapy for glioblastoma","volume":"14","author":"Wang","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejps.2019.105094_bib0090","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.3171\/2015.1.FOCUS14743","article-title":"Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals","volume":"38","author":"Wang","year":"2015","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.ejps.2019.105094_bib0091","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nm988","article-title":"Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer","volume":"10","author":"Willett","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejps.2019.105094_bib0092","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejps.2019.105094_bib0093","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11060-008-9533-5","article-title":"Nitrosourea efficacy in high-grade glioma: a survival gain analysis summarizing 504 cohorts with 24193 patients","volume":"88","author":"Wolff","year":"2008","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.ejps.2019.105094_bib0094","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005724","article-title":"Quantifying the effects of antiangiogenic and chemotherapy drug combinations on drug delivery and treatment efficacy","volume":"13","author":"Yonucu","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejps.2019.105094_bib0095","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijpharm.2018.12.065","article-title":"Delivery of liposome encapsulated temozolomide to brain tumour: understanding the drug transport for optimisation","volume":"557","author":"Zhan","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.105094_bib0096","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.addr.2018.07.013","article-title":"Computational modelling of drug delivery to solid tumour: understanding the interplay between chemotherapeutics and biological system for optimised delivery system","author":"Zhan","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2019.105094_bib0097","doi-asserted-by":"crossref","DOI":"10.1088\/0022-3727\/47\/47\/475401","article-title":"Effect of heterogeneous microvasculature distribution on drug delivery to solid tumour","volume":"47","author":"Zhan","year":"2014","journal-title":"J. Phys. D Appl. Phys."},{"key":"10.1016\/j.ejps.2019.105094_bib0098","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s41048-019-0083-5","article-title":"Towards a multiphysics modelling framework for thermosensitive liposomal drug delivery to solid tumour combined with focused ultrasound hyperthermia","volume":"5","author":"Zhan","year":"2019","journal-title":"Biophys. Rep."},{"key":"10.1016\/j.ejps.2019.105094_bib0099","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2018.07.006","article-title":"Convection enhanced delivery of liposome encapsulated doxorubicin for brain tumour therapy","volume":"285","author":"Zhan","year":"2018","journal-title":"J. Controll. Release"},{"key":"10.1016\/j.ejps.2019.105094_bib0100","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.mvr.2006.12.003","article-title":"Effect of heterogeneous vasculature on interstitial transport within a solid tumor","volume":"73","author":"Zhao","year":"2007","journal-title":"Microvasc. Res."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719303677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719303677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:50:16Z","timestamp":1760529016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098719303677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":100,"alternative-id":["S0928098719303677"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2019.105094","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Convection enhanced delivery of anti-angiogenic and cytotoxic agents in combination therapy against brain tumour","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2019.105094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105094"}}